The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 22, 2021

Filed:

Jan. 06, 2017
Applicant:

Biomarin Pharmaceutical Inc., Novato, CA (US);

Inventor:

Emil D. Kakkis, Novato, CA (US);

Assignee:

BIOMARIN PHARMACEUTICAL INC., Novato, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 38/46 (2006.01); A61K 38/47 (2006.01);
U.S. Cl.
CPC ...
A61K 38/465 (2013.01); A61K 9/0085 (2013.01); A61K 38/47 (2013.01); C12Y 301/06008 (2013.01); C12Y 302/0105 (2013.01);
Abstract

The present invention relates to the intrathecal (IT) administration of recombinant enzyme to treat lysosomal storage disorders. In an exemplary embodiment, intrathecal administration of human α-L-iduronidase (rhIDU) injections in MPS I affected animals resulted in significant enzyme uptake, significant rh-iduronidase activity in brain and meninges and a decrease of glycosaminoglycan (GAG) storage in cells of MPS I subjects to that of normal subjects. Intrathecal administration proved more effective than intravenous treatment at alleviating MPS I symptoms, indicating it is a useful method of treating lysosomal storage disorders.


Find Patent Forward Citations

Loading…